You are here

Molecular Imaging

 

St. Louis-based Mallinckrodt closed the $690 million sale of its nuclear imaging division to IBA Molecular, a national supplier of radiopharmaceutical products.

For years now, research has emerged to show the effects of playing football—including repetitive concussive and sub-concussive hits—may lead to major brain damage. Now, a new study further explores the topic and affirms that players in the National Football League (NFL) could be at a higher risk for brain injuries.

Putting assumptions to rest in neuroscience, a group of researchers used an MRI approach and found that the connectivity patterns in your brain are unique to you.

Ionizing radiation from medical scans may be implicated in Alzheimer’s disease, according to a Danish study published in Oncotarget.

Katrina Pitas, vice president of business development for SHINE Medial Technologies, is in St. Louis this week to speak at the 2016 Mo-99 Topical Meeting. While preparing for her presentation, she spoke with Health Imaging about what SHINE has been up to this year and what she will be discussing at the meeting. 

 

Recent Headlines

Gamma Medica, Hospital Services Limited to expand into European breast imaging market

Gamma Medica, a molecular breast imaging (MBI) technology company, reached an agreement with Hospital Services Limited (HSL), a medical device company that distributes, installs and services radiology capital equipment and medical devices.

MRI detects signs of autism in high-risk infants

Researchers, who used MRI on infants who have older siblings with autism, were able to correctly predict about 80 percent of those infants who would later develop autism.

Mallinckrodt sells nuclear imaging business to IBA Molecular for $690 million

St. Louis-based Mallinckrodt closed the $690 million sale of its nuclear imaging division to IBA Molecular, a national supplier of radiopharmaceutical products.

Researchers pinpoint genetic risk factors for breast cancer

Clinicians may be able to more accurately predict a woman’s risk of breast cancer, as researchers from the University of Adelaide and the Hospital Research Foundation have identified a gene that contributes to tumor development in women with dense breasts.

Engineering company to test thrombectomy device in clinical trial

Amnis Therapeutics, a biomedical engineering company in Israel, has received approval from the Karolinska Institute, a medical university in Stockholm, Sweden, to use its neuro-thrombectomy device on patients for the first time in a clinical trial.

Parental obesity linked to slow development in children

A new study from the National Institutes of Health (NIH) found a link between slow development in young children and obesity rates of parents.

fMRI used to analyze psychotropic drug use in autistic patients

Neuroscientists from Rutgers University have found that trying to control bodily movement and treating children with autism using psychotropic drugs may worsen their neuromotor problems.

 
Intraoperative imaging technology cuts need for repetitive lumpectomy

Lightpoint Medical, developers of medical imaging technologies, has announced results for its clinical trial in regards to intraoperative imaging technology for breast cancer surgery.

Could herpes meds slow down the onset of Alzheimer’s?

Existing research that shows a medication designed to treat herpes could also be beneficial to individuals suffering with Alzheimer’s. The treatment is being tested in a new clinical study.

PET scans show patients with PTSD have imbalance in brain's signalling systems

Researchers set out to study patients with post-traumatic stress disorder (PTSD) using PET scans. They found that a greater imbalance between two neurochemical systems in the brain—serotonin and substance P—meant individuals were more likely to experience PTSD symptoms.

Pages